Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
rhTPO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Previously Treated Primary Immune Thrombocytopenia
1 trial -
risperidone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Neuroleptic-Induced Tardive Dyskinesia
1 trial -
saproterin dihydrochloride
BioMarin Pharmaceutical Australia Pty Ltd
Phenylketonuria
1 trial -
sodium oxybate
Jazz Pharmaceuticals Ireland Limited
Sleep
1 trial -
suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain, Acute Postoperative
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial -
transdermal nicotine replacement therapy
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
7 g Ispaghula
IRONWOOD PHARMACEUTICALS INC
Healthy
1 trial -
75 mg acetylsalicylic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Preeclampsia
1 trial -
ANKASCIN 568-P Red yeast rice capsules
Biotech Pharmaceutical Co.,
Hyperlipidemias
1 trial -
AVN944
Vertex Pharmaceuticals (Australia) Pty.
Refractory Solid Tumors
1 trial -
Acetaminophen
Hospital Authority, Hong Kong
Elbow Fracture
1 trial -
Aescin in Horse Chestnut
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Anorectal Disorder
1 trial -
Alcohol(oral) and placebo
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Drinking
1 trial -
Apolipoprotein (ApoE) detection
Grace Therapeutics
Senile Plaques
1 trial -
Benralizumab
Grace Therapeutics
Asthma; Eosinophilic
1 trial -
Blood draw for Lp(a)
Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
1 trial -
Botulinum Toxin Type A Injection [Botox]
The First People's Hospital of Lianyungang
Rosacea
1 trial -
Budesonide/formoterol
The First People's Hospital of Lianyungang
COPD Exacerbation
1 trial -
Bupivacain
Hospital Authority, Hong Kong
Arthroplasty, Replacement, Knee
1 trial -
Bupivacaine / fentaNYL
Grace Therapeutics
Depression, Postpartum
1 trial -
Chronotropic Incompetence Diagnostic Algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
ClearSight HPI Monitoring system
Grace Therapeutics
Anesthesia, Epidural
1 trial -
Clostridium butyricum (live) Tablets(Meiya)
Rocket Pharmaceuticals B.V.
Rectal Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources